Skin Cancer (Nonmelanoma)

Curcumin Shows Promise as New Sunscreen Filter
August 27, 2021

It has been 20 years since the FDA approved a new sunscreen filter. However, a recent study evaluating curcumin could change that.

Immunotherapy Helps Manage Skin Disease in Patients with Cancer
August 26, 2021

There are an increasing number of novel immunotherapies available for patients with skin cancer, however, their numerous adverse events must be addressed.

SRT Shows Positive Outcomes for NMSC
August 25, 2021

Part 1 of Dermatology Times®’ coverage of a strategic look at superficial radiation therapy (SRT) presented at the recent Music City SCALE Symposium for Cosmetic Advances & Laser Education 16th Annual Meeting in Nashville, Tennessee, showcases this therapy’s efficacy in treating keratinocytic skin cancers.

Study: Curcumin Nanoparticles as a Photoprotective Adjuvant
August 24, 2021

Curcumin has a long history as an effective treatment for everything from chronic pain to skin infections. Nanoparticle encapsulation shows promise in meeting that challenge and opening the way for a safe, effective adjuvant to sunscreen.

Remetinostat Demonstrates Clinical Efficacy in BCC
August 13, 2021

A phase 2 clinical trial on remetinostat for the treatment of BCC in adult patients has been published in the Clinical Cancer Research journal and shows promising results.

Valisure CEO Shares Thoughts on Johnson & Johnson Sunscreen Recall
August 04, 2021

In this video interview, David Light, CEO of Valisure, shares his thoughts on the recent sunscreen recall from Johnson & Johnson due to benzene contamination and reveals how the FDA and sun protection companies can make sure this never happens again.

Physician Provides Update on Benzene Contamination in Sunscreens
July 29, 2021

In this exclusive video interview, Christopher Bunick, MD, PhD, gives Dermatology Times an update on benzene contamination being detected in various sunscreens and after-sun care products, as well as a recent recall by Johnson & Johnson.

The Cutaneous Connection: Episode 27- Benzene Contamination Update
July 22, 2021

Christopher Bunick, MD, PhD, provides an update on benzene contamination in sunscreen, including a recent recall from Johnson & Johnson.

FDA Approves Pembrolizumab for Locally Advanced cSCC
July 07, 2021

The FDA has expanded the label for pembrolizumab for use as a monotherapy in the treatment of patients with locally advanced cutaneous squamous cell carcinoma that is not curable by surgery or radiation.

Cemiplimab Approved for BCC in Europe
June 25, 2021

The European Commission has approved cemiplimab for the treatment of locally advanced or metastatic basal cell carcinoma in adults.